ViiV Healthcare and TREAT Asia, a Bangkok-based program of amfAR, The Foundation for AIDS Research, announced a…two-year partnership that aims to improve access and optimize the quality of healthcare for infants and children living with HIV across Asia…ViiV Healthcare will enable TREAT Asia to build on its extensive regional pediatric HIV program...The data generated through this partnership will create an evidence base from which to identify best practices in ART [antiretroviral therapy] management to delay first-line failure…A major part of the initiative will be to develop medical education programs built on the clinical experience and research being done by TREAT Asia’s network of pediatric HIV providers…The partnership will support interventions and activities in Cambodia, China, India, Indonesia, Malaysia, Thailand, and Vietnam…[refers to GlaxoSmithKline, Pfizer]